Company Overview
Mirion Technologies, Inc. operates within the Industrials sector as a provider of specialized industrial machinery, specifically focusing on radiation detection, measurement, analysis, and monitoring products and services across North America, Europe, and the Asia Pacific regions. The company structures its operations into two distinct segments, Medical, and Nuclear & Safety, with the Medical segment offering solutions for radiation oncology quality assurance and dosimetry. In terms of scale, the firm maintains a market capitalization of $4.94B and employs a workforce of 3281 individuals to support its global product portfolio. These financial metrics and operational scope indicate that Mirion Technologies is an established mid-to-large-cap entity with significant revenue generation capabilities, as evidenced by its trailing twelve-month revenue of $925.40M, positioning it as a substantial player in the niche markets of nuclear safety and medical radiation technology.
Financial Health
The company reports revenue of $925.40M, net income of $28.80M, and EBITDA of $204.80M for the trailing twelve months, revealing a significant gap between operating earnings and net income that underscores a substantial cost structure including taxes, interest, and non-operating expenses. This disparity highlights the impact of overhead costs and financial obligations on the bottom line, reducing the profit margin to 3.1% despite a robust gross margin of 47.4%. The firm generates free cash flow of $126.47M, which provides a critical buffer for financial flexibility, allowing for capital expenditures, potential acquisitions, or debt reduction without relying solely on external financing. Regarding liquidity and leverage, Mirion holds cash reserves of $419.20M against total debt of $1.23B, resulting in a debt-to-equity ratio of 64.36, which indicates a leveraged balance sheet where debt obligations exceed liquid cash assets. The current ratio stands at 2.83, signaling a conservative approach to short-term liquidity management as the company holds nearly three times the current assets required to cover its current liabilities. Return on equity is recorded at 1.7% and return on assets at 1.3%, metrics that suggest capital efficiency is currently low, as management generates minimal returns relative to the shareholders' equity and the total asset base utilized to generate operations.
Valuation Assessment
The valuation metrics show a trailing P/E ratio of 179.00 compared to a forward P/E of 29.46, implying a substantial expectation of significant earnings growth in the future that is required to justify the current high multiple. The price-to-book ratio is 2.58, indicating that the market values the company at a significant premium over its tangible book value, reflecting intangible assets or growth prospects not captured on the balance sheet. Alternative valuation measures such as the price-to-sales ratio of 5.34 and the EV/EBITDA of 27.75 suggest the stock is priced aggressively relative to its sales volume and earnings before interest, taxes, depreciation, and amortization. The 52-week price range spans from a low of $12.00 to a high of $30.28, and based on the forward P/E of 29.46 which often correlates with current pricing in this context, the stock is trading in a position that reflects high market expectations relative to its historical volatility. With a beta of 1.04, the stock exhibits price volatility that is slightly higher than the broader market, meaning it tends to move 4% more than the overall market index during periods of fluctuation.
Growth & Income
Revenue growth stands at 9.1% year-over-year while earnings growth is recorded at 2.4%, indicating that earnings are growing at a much slower pace than revenue, which implies that profitability is facing headwinds from rising costs or margin compression rather than pure volume expansion. As a non-dividend payer, the company does not distribute cash to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm reinvests all of its net income of $28.80M back into the business to fund operations or growth initiatives rather than paying dividends. The overall growth and income profile is characterized by double-digit revenue expansion but modest earnings growth, coupled with a total absence of dividend income, presenting a capital appreciation strategy dependent on future earnings catch-up to align with revenue performance.